[Angiotensin II receptor antagonists reduce the development of nephropathies in type 2 diabetes. Three new studies are of interest, but don't answer all questions].
Nilsson
P
P
Avdelningen för medicin, Universitetssjukhuset MAS, Malmö. Peter.Nilsson@medforsk.mas.lu.se
Attvall
S
S
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D003928:Diabetic Nephropathies / Q000188:drug therapy / Q000517:prevention & control*; D005500:Follow-Up Studies; D006801:Humans; D019808:Losartan / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic
D000959:Antihypertensive Agents; D000804:Angiotensin II; D019808:Losartan